Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
2008.
Current World Literature.
Current Opinion in Ophthalmology,
Vol. 19,
Issue. 6,
p.
541.
Park, Hae Y.
Lee, Na Y.
Kim, Jie H.
and
Park, Chan K.
2008.
Intraocular Pressure Lowering, Change of Antiapoptotic Molecule Expression, and Neuroretinal Changes by Dorzolamide 2%/Timolol 0.5% Combination in a Chronic Ocular Hypertension Rat Model.
Journal of Ocular Pharmacology and Therapeutics,
Vol. 24,
Issue. 6,
p.
563.
Caprioli, Joseph
and
Zeyen, Thierry
2009.
A Critical Discussion of the Rates of Progression and Causes of Optic Nerve Damage in Glaucoma: International Glaucoma Think Tank II: July 25-26, 2008, Florence, Italy.
Journal of Glaucoma,
Vol. 18,
Issue. Supplement 6Supplement 1,
p.
S1.
Guo, Ying
Johnson, Elaine
Cepurna, William
Jia, Lijun
Dyck, Jennifer
and
Morrison, John C.
2009.
Does elevated intraocular pressure reduce retinal TRKB-mediated survival signaling in experimental glaucoma?.
Experimental Eye Research,
Vol. 89,
Issue. 6,
p.
921.
Park, Chan Kee
Cha, Jiook
Park, Soo Chul
Lee, Phil Young
Kim, Jie Hyun
Kim, Hwa Sun
Kim, Shin Ae
Kim, In-Beom
and
Chun, Myung-Hoon
2009.
Differential expression of two glutamate transporters, GLAST and GLT-1, in an experimental rat model of glaucoma.
Experimental Brain Research,
Vol. 197,
Issue. 2,
p.
101.
Thelen, Ulrich
Buchholz, Patricia
and
Kimmich, Friedemann
2009.
Treatment of patients with primary open-angle glaucoma with a fixed combination of brimonidine 0.2%/timolol 0.5%: multicenter, open-label, observational study in Germany.
Current Medical Research and Opinion,
Vol. 25,
Issue. 4,
p.
1003.
Johnson, Elaine C.
Guo, Ying
Cepurna, William O.
and
Morrison, John C.
2009.
Neurotrophin roles in retinal ganglion cell survival: Lessons from rat glaucoma models.
Experimental Eye Research,
Vol. 88,
Issue. 4,
p.
808.
Vidal, Lourdes
Díaz, Florentina
Villena, Alicia
Moreno, Mercedes
Campos, José García
and
Pérez de Vargas, Ignacio
2010.
Reaction of Müller cells in an experimental rat model of increased intraocular pressure following timolol, latanoprost and brimonidine.
Brain Research Bulletin,
Vol. 82,
Issue. 1-2,
p.
18.
Kuno, Noriyuki
and
Fujii, Shinobu
2011.
Recent Advances in Ocular Drug Delivery Systems.
Polymers,
Vol. 3,
Issue. 1,
p.
193.
Kaneko, Emi
Wada, Tomoyuki
Minagawa, Yoko
and
Inoue, Yutaka
2012.
Pharmacological profile and clinical efficacy of brimonidine tartrate (AIPHAGAN^|^reg; ophthalmic solution 0.1%).
Folia Pharmacologica Japonica,
Vol. 140,
Issue. 4,
p.
177.
Park, Hae-Young Lopilly
Kim, Jie Hyun
and
Park, Chan Kee
2014.
Alterations of the synapse of the inner retinal layers after chronic intraocular pressure elevation in glaucoma animal model.
Molecular Brain,
Vol. 7,
Issue. 1,
Dekeyster, Eline
Geeraerts, Emiel
Buyens, Tom
Van den Haute, Chris
Baekelandt, Veerle
De Groef, Lies
Salinas-Navarro, Manuel
Moons, Lieve
and
Badea, Tudor C
2015.
Tackling Glaucoma from within the Brain: An Unfortunate Interplay of BDNF and TrkB.
PLOS ONE,
Vol. 10,
Issue. 11,
p.
e0142067.
Kitaoka, Yasushi
Kojima, Kaori
Munemasa, Yasunari
Sase, Kana
and
Takagi, Hitoshi
2015.
Axonal protection by brimonidine with modulation of p62 expression in TNF-induced optic nerve degeneration.
Graefe's Archive for Clinical and Experimental Ophthalmology,
Vol. 253,
Issue. 8,
p.
1291.
In Jung, Kyoung
Hyun Kim, Jie
and
Kee Park, Chan
2015.
α2-Adrenergic modulation of the glutamate receptor and transporter function in a chronic ocular hypertension model.
European Journal of Pharmacology,
Vol. 765,
Issue. ,
p.
274.
Weinreb, Robert N.
Leung, Christopher K. S.
Crowston, Jonathan G.
Medeiros, Felipe A.
Friedman, David S.
Wiggs, Janey L.
and
Martin, Keith R.
2016.
Primary open-angle glaucoma.
Nature Reviews Disease Primers,
Vol. 2,
Issue. 1,
Nizari, Shereen
Guo, Li
Davis, Benjamin M
Normando, Eduardo M
Galvao, Joana
Turner, Lisa A
Bizrah, Mukhtar
Dehabadi, Mohammad
Tian, Kailin
and
Cordeiro, M Francesca
2016.
Non-amyloidogenic effects of α2 adrenergic agonists: implications for brimonidine-mediated neuroprotection.
Cell Death & Disease,
Vol. 7,
Issue. 12,
p.
e2514.
Cortada, Maurizio
Levano, Soledad
and
Bodmer, Daniel
2017.
Brimonidine Protects Auditory Hair Cells from in vitro-Induced Toxicity of Gentamicin.
Audiology and Neurotology,
Vol. 22,
Issue. 3,
p.
125.
Yukita, Masayoshi
Omodaka, Kazuko
Machida, Shigeki
Yasuda, Masayuki
Sato, Kota
Maruyama, Kazuichi
Nishiguchi, Koji M.
and
Nakazawa, Toru
2017.
Brimonidine Enhances the Electrophysiological Response of Retinal Ganglion Cells through the Trk-MAPK/ERK and PI3K Pathways in Axotomized Eyes.
Current Eye Research,
Vol. 42,
Issue. 1,
p.
125.
Gote, Vrinda
Sikder, Sadia
Sicotte, Jeff
and
Pal, Dhananjay
2019.
Ocular Drug Delivery: Present Innovations and Future Challenges.
Journal of Pharmacology and Experimental Therapeutics,
Vol. 370,
Issue. 3,
p.
602.
Park, Hae-Young Lopilly
Kim, Si Won
Kim, Jie Hyun
and
Park, Chan Kee
2019.
Increased levels of synaptic proteins involved in synaptic plasticity after chronic intraocular pressure elevation and modulation by brain-derived neurotrophic factor in a glaucoma animal model.
Disease Models & Mechanisms,
Vol. 12,
Issue. 6,